Erratum: GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and reelin proteins in cerebellum (Schizophrenia Research (2004) 72:2-3 (109-122) DOI: 10.1016/j.schres.2004.02.017);GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum

Schizophrenia Research

Volumn 72, Issue 2-3, 2005, Pages 109-122

  Hossein Fatemi, S ^a   Stary, Joel M ^a   Earle, Julie A ^a   Araghi Niknam, Mohsen ^a   Eagan, Elisabeth ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Cerebellum; GAD 65 67 kDa proteins; Major depression; Postmortem; Reelin; Schizophrenia; Western blotting

Indexed keywords

BETA ACTIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; ISOPROTEIN; REELIN; REELIN 180; REELIN 330; REELIN 410; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN DYSFUNCTION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; HYPOTHESIS; ISOMER; MAJOR DEPRESSION; MALE; MEASUREMENT; MOOD DISORDER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHIZOPHRENIA; WESTERN BLOTTING;

EID: 9244249796     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.12.001     Document Type: Erratum

References (64)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry. 52:1995;258-266
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed.:1994;66-71 American Psychiatric Press, Washington, DC
3. Bacci J.J., Salin P., Kerkerian-Le Goff L. Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model. Synapse. 46:2002;224-234
4. Caviness V.S. Jr., Sidman R.L. Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice: an autoradiographic analysis. J. Comp. Neurol. 148:1973;141-151
5. Costa E., Davis J., Pesold C., Tueting P., Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2:2002;56-62
6. Curristin S.M., Cao A., Stewart W.B., Zhang H., Madri J.A., Morrow J.S., Ment L.R. Disrupted synaptic development in the hypoxic newborn brain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;15729-157344
7. DeSilva U., D'Arcangelo G., Braden V.V., Chen J., Miao G.G., Curran T., Green E.D. The human reelin gene: isolation, sequencing, and mapping on chromosome 7. Genome Res. 7:1997;157-164
8. Eastwood S.L., Law A.J., Everall I.P., Harrison P.J. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol. Psychiatry. 8:2003;148-155
9. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100
10. Esclapez M., Tillakaratne N.J., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14:1994;1834-1855
11. Falconer D.S. Two new mutants, Trembler and 'Reeler', with neurological actions in the house mouse. J. Genet. 50:1951;182-201
12. Fatemi S.H. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry. 6:2001;129-133
13. Fatemi S.H. The role of Reelin in pathology of autism. Mol Psychiatry. 7:2002;919-920
14. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., Shier A., Sheikh S., Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry. 4:1999;145-154
15. Fatemi, S.H., Earle, J.A., McMenomy, T., 2000. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry, 5, 654-63, 571.
16. Fatemi S.H., Kroll J.L., Stary J.M. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. NeuroReport. 12:2001;3209-3215
17. Fatemi S.H., Stary J.M., Halt A.R., Realmuto G.R. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J. Autism Dev. Disord. 31:2001;529-535
18. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry. 52:2002;805-810
19. Fatemi S.H., Stary J.M., Egan E.A. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell. Mol. Neurobiol. 22:2002;139-152
20. Feldblum S., Erlander M.G., Tobin A.J. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34:1993;689-706
21. Forster E., Tielsch A., Saum B., Weiss K.H., Johanssen C., Graus-Porta D., Muller U., Frotscher M. Reelin, Disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 99:2002;13178-13183
22. Goffinet A.M. An early development defect in the cerebral cortex of the reeler mouse. A morphological study leading to a hypothesis concerning the action of the mutant gene. Anat. Embryol. (Berl.). 157:1979;205-216
23. Goffinet A.M. Events governing organization of postmigratory neurons: studies on brain development in normal and reeler mice. Brain Res. 319:1984;261-296
24. Goffinet A.M. The reeler gene: a clue to brain development and evolution. Int. J. Dev. Biol. 36:1992;101-107
25. Gold B.I., Bowers M.B. Jr., Roth R.H., Sweeney D.W. GABA levels in CSF of patients with psychiatric disorders. Am. J. Psychiatry. 137:1980;362-364
26. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E., DiGiorgi Gerevini V. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry. 57:2000;1061-1069
27. Heckers S., Stone D., Walsh J., Shick J., Koul P., Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry. 59:2002;521-529
28. Herman J.P., Renda A., Bodie B. Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons. Biol. Psychiatry. 53:2003;166-174
29. Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O., Martin N.D., Walsh C.A. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 26:2000;93-96
30. Honig A., Bartlett J.R., Bouras N., Bridges P.K. Amino acid levels in depression: a preliminary investigation. J. Psychiatr. Res. 22:1988;159-164
31. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15718-15723
32. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51:1994;8-19
33. Knable M.B., Torrey E.F., Webster M.J., Bartko J.J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res. Bull. 55:2001;651-659
34. Knable M.B., Barci B.M., Bartko J.J., Webster M.J., Torrey E.F. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry. 7:2002;392-404
35. Knable M.B., Barci B.B., Bartko J.J., Webster M.S., Torrey E.F. Molecular abnormalities of the hippocampus in severe mental illness: post-mortem findings from the Stanley Neuropathology Consortium. Schizophr. Res. 60:2003;645
36. Labarca R., Silva H., Jerez S., Ruiz A., Renterias P., Ogalde C., Bustos G. Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients. Schizophr. Res. 16:1995;83-85
37. Lacor P.N., Grayson D.R., Auta J., Sugaya I., Costa E., Guidotti A. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3556-3561
38. Laprade N., Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse. 33:1999;36-48
39. Levine J., Panchalingam K., Rapoport A., Gershon S., McClure R.J., Pettegrew J.W. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol. Psychiatry. 47:2000;586-593
40. Luque J.M., Morante-Oria J., Fairen A. Localization of ApoER2, VLDLR and Dab1 in radial glia: groundwork for a new model of reelin action during cortical development. Brain Res., Dev. Brain Res. 140:2003;195-203
41. Magdaleno S., Keshvara L., Curran T. Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice. Neuron. 33:2002;573-586
42. Martin D.L., Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60:1993;395-407
43. Molnar M., Potkin S.G., Bunney W.E., Jones E.G. MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol. Psychiatry. 53:2003;39-47
44. Niculescu A.B., Kelsoe J.R. Finding genes for bipolar disorder in the functional genomics era: from convergent functional genomics to phenomics and back. CNS Spectr. 7:2002;215-226
45. Ogawa M., Miyata T., Nakajima K., Yagyu K., Seike M., Ikenaka K., Yamamoto H., Mikoshiba K. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron. 14:1995;899-912
46. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience. 93:1999;441-448
47. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., Caruncho H.J. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3221-3226
48. Petty F. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin. Chem. 40:1994;296-302
49. Petty F., Schlesser M.A. Plasma GABA in affective illness. A preliminary investigation. J. Affect. Disord. 3:1981;339-343
50. Petty F., Sherman A.D. Learned helplessness induction decreases in vivo cortical serotonin release. Pharmacol. Biochem. Behav. 18:1983;649-650
51. Petty F., Kramer G.L., Fulton M., Moeller F.G., Rush A.J. Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacology. 9:1993;125-132
52. Quattrocchi C.C., Wannenes F., Persico A.M., Ciafre S.A., D'Arcangelo G., Farace M.G., Keller F. Reelin is a serine protease of the extracellular matrix. J. Biol. Chem. 277:2002;303-309
53. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., De Camilli P. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J. 10:1991;1275-1284
54. Rodriguez M.A., Pesold C., Liu W.S., Kriho V., Guidotti A., Pappas G.D., Costa E. Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3550-3555
55. Sherman A.D., Davidson A.T., Baruah S., Hegwood T.S., Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci. Lett. 121:1991;77-80
56. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23:2003;297-302
57. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why? Trends Pharmacol. Sci. 19:1998;500-505
58. Thaker G.K., Tamminga C.A., Alphs L.D., Lafferman J., Ferraro T.N., Hare T.A. Brain gamma-aminobutyric acid abnormality in tardive Dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Arch. Gen. Psychiatry. 44:1987;522-529
59. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44:2000;151-155
60. Tortorella A., Monteleone P., Fabrazzo M., Viggiano A., De Luca L., Maj M. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology. 44:2001;167-171
61. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., Pesold C. The phenotypic characteristics of heterozygous reeler mouse. NeuroReport. 10:1999;1329-1334
62. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry. 57:2000;237-245
63. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277:2002;39944-39952
64. Weissman M.M., Leaf P.J., Tischler G.L., Blazer D.G., Karno M., Bruce M.L., Florio L.P. Affective disorders in five United States communities. Psychol. Med. 18:1988;141-153